Clinical Trial: A Study to Determine the Metabolism and Excretion of [14C]E2086 in Healthy Male Participants

U.S., Dec. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07308236) titled 'A Study to Determine the Metabolism and Excretion of [14C]E2086 in Healthy Male Participants' on Dec. 15.

Brief Summary: The primary purpose of this study is to determine the metabolism and excretion of [14C]E2086 in healthy male participants.

Study Start Date: Dec. 31

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: E2086

E2086 oral capsule.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Eisai Inc.

Disclaimer: Curated by HT Syndication....